NCT04976777 - A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

February 9, 2022

Study Completion Date

February 9, 2022

Conditions

Macular Edema

Interventions

DEVICE

Updated DEX PS DDS Applicator

Intravitreal Administration

DEVICE

Approved DEX PS DDS Applicator

Intravitreal administration

DRUG

Dexamethasone

Dexamethasone 0.7 mg in a solid polymer drug delivery system

Trial Locations (7)

Texas Retina Associates /ID# 231305, Arlington

Global Research Management /ID# 238944, Glendale

Advanced Eye Centers Inc /ID# 233429, North Dartmouth

Discover Vision Centers /ID# 239366, Independence

Charleston Neurosciences Institute /ID# 238521, Charleston

Retina Research Institute of Texas /ID# 231420, Abilene

North Texas Retina Consultants /ID# 241013, Willow Park